Le Lézard
Classified in: Health, Business
Subjects: MAV, CCA, SHM

/R E P E A T -- MEDIA BRIEFING - 2023 METRO ANNUAL GENERAL MEETING OF SHAREHOLDERS/


MONTREAL, Jan. 17, 2023 /CNW Telbec/ - METRO (TSX: MRU) will hold its Annual General Meeting of Shareholders and will announce its results for the first quarter of fiscal year 2023 on Tuesday, January 24, 2023. On this occasion, three virtual events will be held, including a media briefing at 11:15 a.m. 

Information:

Annual General Meeting of Shareholders
Tuesday, January 24, 2023 at 10 a.m.

To access the webcasting platform, click here. Please note that you will only be able to login from 9:45 a.m. on the morning of the event, using the "Guest" function.

Media briefing at 11:15 a.m.

Members of the media are invited to virtually meet with Eric La Flèche, President and CEO, and François Thibault, Executive Vice President, Chief Financial Officer and Treasurer, at 11:15 a.m. Please email [email protected] to register and receive the link for access to the platform where you will have the opportunity to ask your questions. Please note, this meeting is for media representatives only. Pre-registration is required.

Reminder - Call at 1:30 p.m.

The company will hold a call for investors and financial analysts at 1:30 pm. Click here for more details.

About METRO Inc.

With annual sales of $18 billion, METRO Inc. is a food and pharmacy leader in Québec and Ontario. Its purpose is to Nourish the health and well-being of our communities. As a retailer, franchisor, distributor, and manufacturer, the company operates or services a network of some 950 food stores under several banners including Metro, Metro Plus, Super C and Food Basics, as well as some 650 drugstores primarily under the Jean Coutu, Brunet, Metro Pharmacy and Food Basics Pharmacy banners, providing employment to more than 90,000 people. For more details, visit corpo.metro.ca.

SOURCE METRO INC.


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...



News published on and distributed by: